Liver blood marker testing in UK primary care: a UK wide cohort study, 2004-2016.

The striking finding that AST is now only measured in a fraction of the population has significant implications for routine guidance which frequently expects it. A more nuanced approach where non-invasive markers are targeted towards individuals with risk factors for CLD may be a solution.